@QasimRazaMD Kudos to the investigators on the first randomized trial of mech thrombectomy against standard of care. A more imp question is the 3-6 month outcome. I m curious to know the residual clot burden and CTED with heparin alone.
Here are my takeaways for the 7 most relevant and important #ESCCongress2025 for generalists
AQUATIC, HI-PRO, RETREAT-FRAIL, DIGIT-HF, DAN-RSV were most practicing changing
POTCAST was most contentious - not as billed
Today we celebrated the success of our PERT program with our dedicated and exceptional team. The goal remains to select appropriate cases to improve outcomes in our patients with venous thromboembolism @ECUHealthNC@pras_senMD@PaulMahoneyMD
What do PE thrombectomy docs do for post lytic cases? How long do you wait to assess lytic success or failure? This is an example of thrombectomy performed 6-8 hours post full dose lytics with worsening shock.
The Sideclose technique for #Impella access site bleeding new in @MyJSCAI. Stop the bleeding, keep the Impella! @jason_wollmuth #MCS
https://t.co/IZp8ydLgfJ
Complete revascularization is now "a must" in ACS, but the optimal timing remains a matter of controversy: immediate? Staged in-hospital? Staged within 45 days? Staged when you want?
This prespecified analysis of the randomized BIOVASC trial suggests that immediate complete revascularization is safe in both patients with two-vessel disease and those with three-vessel disease.
The authors conclude that immediate complete revascularization is a feasible alternative to a staged approach for extensive and complex coronary disease and could represent a novel treatment paradigm.
Article: https://t.co/oEjLw860lU
Editorial: https://t.co/B5PU9qFtMP
@pras_senMD@AQaviMD@QasimRazaMD Nice! Picture from our case. Important to have the stent as far into the outflow graft as possible. Luckily the gap didnโt prove to be an issue as the gradient resolved completely.
@GreggWStone@willsuh76 IABP wasnโt used in the control arm. I would imagine many operators in the US use that in stage C shock. Is this trial enough to change that practice?